Vadadustat

Modify Date: 2024-01-06 10:45:55

Vadadustat Structure
Vadadustat structure
Common Name Vadadustat
CAS Number 1000025-07-9 Molecular Weight 306.70100
Density N/A Boiling Point N/A
Molecular Formula C14H11ClN2O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Vadadustat


Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia.

 Names

Name vadadustat
Synonym More Synonyms

 Vadadustat Biological Activity

Description Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia.
Related Catalog
In Vitro Vadadustat induces endogenous erythropoietin synthesis and enhances iron mobilization. Vadadustat is well-tolerated in healthy volunteers and patients with chronic kidney disease, where it increases reticulocytes, plasma EPO, and Hb levels in a dose-dependent manner. The increase in plasma EPO levels seen with vadadustat is comparable in magnitude to that occurring physiologically at moderate altitude and shows a normal diurnal pattern with a return to baseline levels prior to the next dose. Vadadustat improves iron homeostasis by decreasing hepcidin and increasing transferrin levels. once-daily oral administration of vadadustat, titrated to increase and maintain Hb in the target range, may provide multiple advantages over conventional ESAs[1]. Vadadustat is observed to have a half-life of approximately 4.5 hours. Overall, patients demonstrate an increase in Hb levels, from 9.91 g/dL at baseline to 10.54 g/dL by day 29. Ferritin levels decrease from 334.1 ng/mL at baseline to 271.7 ng/mL by day 29[2].
References

[1]. Pergola PE, et al. Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease. Kidney Int. 2016 Nov;90(5):1115-1122.

[2]. Gupta N, et al. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD. Am J Kidney Dis. 2017 Feb 24. pii: S0272-6386(17)30110-5.

 Chemical & Physical Properties

Molecular Formula C14H11ClN2O4
Molecular Weight 306.70100
Exact Mass 306.04100
PSA 99.52000
LogP 2.31290
Storage condition 2-8℃

 Synonyms

N-[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]glycine
{[5-(3-chlorophenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid
{[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid
{[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid
{[5-(3-chlorophenyl)-3-hydroxypyridin-2-yl]carbonylamino}acetic acid
{[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid
Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: Vadadustat
  • Price: $550.0/100mg $1000.0/250mg $1900.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao


Get all suppliers and price by the below link:

Vadadustat suppliers


Price: $118/10mM*1mLinDMSO

Reference only. check more Vadadustat price

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3